The latest data presented at VIVA

VIVA's virtual conference will once again feature our much-anticipated Late-Breaking Clinical Trials sessions. A multidisciplinary, international panel of expert physicians, scientists, and regulators will ask questions and shed light on the lasting impact of the research results as they are presented for the first time. Media outlets are invited to view the presentations by registering at

Clinical trial results to be released, in order of presentation:

Friday, November 6, beginning at 11:00am PT

5-Year Outcomes from the IN.PACT Global Study
Thomas Zeller, MD, PhD

Drug-Coated Devices & Limb Outcomes After Endovascular Peripheral Artery Revascularizations
Connie N. Hess, MD, MHS

Standard vs Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism
Efthymios Avgerinos, MD, PhD, MSc

VIVO Study 12-Month Endpoint Results
Anthony Comerota, MD

PROMISE I 1-Year Results
Daniel Clair, MD

Saturday, November 7 beginning at 7:00am PT

DISRUPT PAD III RCT Acute Results: IVL vs PTA in Severe Calcium
William A. Gray, MD

REALITY Study: Directional Atherectomy Vessel Preparation Prior to DCB Angioplasty
Krishna Rocha-Singh, MD

24-Month Outcomes from the DETOUR 1 Trial for Percutaneous Femoropopliteal Bypass
Ehrin Armstrong, MD

2-Year Outcomes of a Multi-Centre Study on Infrapopliteal Bioresorbable Vascular Scaffold
Steven Kum, MD

4-Year DCB Mortality Across ILLUMENATE RCTs
Sean Lyden, MD


VIVA embargoes information presented in the Late-Breaking Clinical Trials sessions from becoming public until after the commencement of the assigned session as listed in the VIVA20 program or on the official VIVA website. No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented. Presentation times will be provided and listed in VIVA course materials. All times are listed in Pacific Standard Time (PST).